Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis

Published:2024-05 Issue:5 Volume:23 Page:103536
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Martel Marie-Elise,Leurs Amélie,Launay David,Behal Hélène,Chepy Aurélien,Collet Aurore,Sanges Sébastien,Hachulla Eric,Dubucquoi Sylvain,Dauchet Luc,Sobanski Vincent

Funder

Lille University Hospital

Publisher

Elsevier BV

Reference80 articles.

1. Systemic sclerosis;Denton;Lancet Lond Engl,2017

2. Can antinuclear antibodies have a pathogenic role in systemic sclerosis?;Chepy;Front Immunol,2022

3. The future of treatment in systemic sclerosis: can we design better trials?;Pope;Lancet Rheumatol,2020

4. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements;Hoffmann-Vold;Lancet Rheumatol,2020

5. Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: diagnostic utility of their separate detection;Menéndez;Autoimmunity,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review;Rheumatology;2024-07-31

2. Research Progress in pathogenesis of connective tissue disease-associated interstitial lung disease from the perspective of pulmonary cells;Autoimmunity Reviews;2024-07